A plasmid was constructed to generate RNA complementary to the /8-galactosidase mRNA under control of the phage X PL promoter. When this anti-mRNA was produced, synthesis of 13-galactosidase was dramatically inhibited (98% (1, 3) . Knowledge of this has been used effectively to block translation in cell-free extracts. In vitro, hybrid-arrested translation has been reported to prevent the synthesis of specific proteins (4, 5) and has been used to detect recombinant DNA molecules containing sequences complementary to a given mRNA. The procedures of hybrid-arrested translation involve DNARNA hybridization, wherein the double-stranded DNA is denatured by heating and annealed with a population of mRNA molecules. Hybridization of DNA to the mRNA effectively blocked translation of these mRNA molecules that formed hybrids.
Inhibition of translation has been efficiently carried out by antibiotics and other inhibitors of protein synthesis (1) . In specific instances, physiological mechanisms have been manipulated to turn on or off genes such as the lac operon of Escherichia coli grown in the presence or absence, respectively, of a 0-galactoside (see ref.
2). However, no general method has been described to block the translation of a specific mRNA molecule.
It has been known that RNA with substantial structure, such as double-stranded RNA, serves as a poor template for protein synthesis (1, 3) . Knowledge of this has been used effectively to block translation in cell-free extracts. In vitro, hybrid-arrested translation has been reported to prevent the synthesis of specific proteins (4, 5) and has been used to detect recombinant DNA molecules containing sequences complementary to a given mRNA. The procedures of hybrid-arrested translation involve DNARNA hybridization, wherein the double-stranded DNA is denatured by heating and annealed with a population of mRNA molecules. Hybridization of DNA to the mRNA effectively blocked translation of these mRNA molecules that formed hybrids.
To develop a method to block the translation of specific mRNA molecules in intact cells, we postulated that RNA complementary to mRNA would also effectively block translation if RNA-RNA hybridization would occur readily under physiological conditions within the cell. Because single-stranded complementary RNA molecules can be readily generated within cells by appropriate vectors, the hypothesis could be tested conveniently. The (10) . Fragments were isolated from the gels by the method of Schmitt and Cohen (11) .
Construction of Plasmids. Phage M13mp7 was used to isolate a BamHI/Cla I fragment containing some of the sequence coding for the NH2-terminal region of,-galactosidase, beginning at amino acid 6 (Fig. 1) . The plasmid pRC23, which contains the phage X PL promoter, was cut with restriction endonucleases Cla I and BamHI. The large Cla I/BamHI fragment from the plasmid was isolated and ligated to the small BamHI/Cla I fragment containing part of the lacZ as described above (Fig. 1 ). Ligations were performed in 66 mM Tris HCI, pH 7.5/5 mM MgCl2/5 mM dithiothreitol/1 mM ATP for 16 hr at 15°C. DNA concentration was between 1 and 10 nM and phage T4 DNA ligase was used at 300 units/ml. The result was a plasmid, pBD4/lacZ'-(rev), containing a lacZ gene fragment in reverse orientation with respect to the PL promoter. This plasmid was transfected into E. coli 294 harboring the compatible plasmid pRK248cIts containing the temperature-sensitive X repressor clts (7) (8) (9) . Little or no anti-mRNA would be synthesized at 30°C. At 42°C, anti-lacZ mRNA would be synthesized at high levels.
Growth of Bacteria. E. coli 294(pRK248cIts) harboring pRC23 or pBD4/lacZ'(rev) was grown in 10 ml of M9 medium containing 1% glycerol overnight at 30°C. To start the experiment, two flasks containing 150 ml of fresh M9 medium (1% glycerol) were inoculated with the E. coli containing pRC23 and another two flasks containing the same medium Abbreviation: IPTG, isopropyl A-D-thiogalactoside.
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were inoculated with the E. coli containing pBD4/lacZ'-(rev). These were grown at 30'C until the optical density at 600 nm reached about 0.5. At this point, isopropyl ,/-D-thiogalactoside (IPTG) was added to one flask of each of the cultures to a final concentration of 1 mM. Aliquots of each of the four cultures were removed and placed at 00C at the starting time of induction (0 min). The cultures were then placed in a 420C water bath and shaken vigorously. Aliquots from each of the four cultures were taken at 15, 30, 60, 90, and 120 min and placed at 0C until assayed a short time later.
Enzyme Assays. Assays for B-galactosidase, lactose permease, transacetylase, and alkaline phosphatase were performed as described (12) (13) (14) (15) . Enzyme concentrations were determined from the linear portions of the curves in all cases. The specific procedures are given below.
Assay of p-galactosidase. 8-Galactosidase was measured as described (12) with minor modifications. Samples of bacterial cultures were diluted with Z buffer (50 mM sodium phosphate, pH 7.0/10 mM KCl/1 mM MgSO4/50 mM 2-mercaptoethanol) into a total volume of 1.1 ml. Two drops of chloroform and one drop of 0.1% sodium dodecyl sulfate were added, after which tubes were swirled on a Vortex mixer for 10 sec. The tubes were then placed in a water bath for 5 min at 30°C. A 1-ml sample was then added to a cuvette.
The reaction was started by adding 0.2 ml of o-nitrophenyl ,3-D-galactoside (4 mg/ml) and lnixed for a few seconds. The cuvette was then placed in a Beckman DU-8 spectrophotometer which was programmed to determine changes in absorbance at 420 nm per min.
Assay of lac carrier protein. Lactose permease was assayed as described (12, 13) with modifications as noted below. Aliquots of bacterial suspensions were centrifuged at 10,000 x g for 5 min. The pellets were washed with 2 ml of 0.1 M potassium phosphate buffer, pH 7.5, containing 10 mM MgSO4 and resuspended in 0.2 ml of the same buffer. In each of four tubes, 50 ,ul of the bacterial suspension was added, after which they were incubated at 26°C for 5 min. With a Hamilton syringe, 2 ,l of 10 mM [14C]methyl 3-D-thiogalactopyranoside (New England Nuclear; 22.5 mCi/ml; specific activity 25.6 Ci/mmol; 1 Ci = 37 GBq) was added to each of the four tubes for 0, 15, 30, and 60 sec. The reaction was stopped by the addition of 3.5 ml of 0.1 M potassium phosphate buffer, pH 5.5, containing 100 mM LiCl. The solution was filtered on a 25-mm 0.45-gm Amicon filter (no. 041255) and washed with 3.5 ml of the same solution. The radioactivity on the filter was then measured in 10 ml of Bray's solution in a scintillation spectrometer.
Assay of thiogalactoside transacetylase. Aliquots of bacterial suspension were centrifuged at 10,000 x g for 5 min. The pellets, resuspended in 250 ,ul of 50 MM Tris HC1, pH 7.8, were assayed for thiogalactoside transacetylase as reported (14) . The suspensiohs were sonicated twice for 15 sec on ice. The extracts were heated at 70°C for 5 min and centrifuged in a Microfuge for 15 min. Each supernatant was transferred to a fresh tube. The reaction was started by mixing 0.5 ml of a solution consisting of 50 mM Tris HCl at pH 7.8, 2 mM EDTA, 1 mM 5,5'-dithiobis(2-nitrobenzoic acid), 0.1 mM acetyl-CoA, and 50 mM IPTG with 200 ,l of the bacterial extracts. The solution was transferred to a cuvette, which was placed in a Beckman DU-8 spectrophotometer that was programmed to calculate changes in absorbance at 412 nm as a function of time.
Assay of alkaline phosphatase. Aliquots of bacterial suspensions were centrifuged at 10,000 x g for 5 min. The pellets were washed in 2 ml of 0.1 M Tris-HCl, pH 7.4. After centrifugation, the pellets were resuspended in 2 ml of the same buffer. The assay consisted of mixing 0.5 ml of the bacterial suspension with 1 ml of 1 M Tris HCl, pH 8.8, and incubating at 37°C for 5 min. The reaction was started by the addition of 0.5 ml of 0.04 M p-nitrophenyl phosphate and the mixture was incubated at 37°C. At 30, 60, and 120 min, 0.7 ml was centrifuged in a Microfuge for 5 min and the supernatant was transferred to a fresh tube. The absorbance at 420 nm was measured in a spectrophotometer and the change per min was determined from the readings at different times.
RESULTS
When E. coli 294 containing the parental plasmid pRC23 was induced at 42°C with IPTG, there was a rapid rise in synthesis of p-galactosidase (Fig. 2) . When E. cOli 294 with the plasmid containing the reverse orientation was induced, the rise inB-galactosidase synthesis on induction with IPTG was essentially prevented. The thesis of lactose permease and thiogalactoside transacetylase encoded by the same polycistronic message, these enzymes were also assayed in the same series of cultures with and without induction with IPTG (Figs. 3 and 4) . The permease and transacetylase were induced concomitantly with pB-galactosidase; however, their synthesis was not inhibited as much as that ofl-galactosidase by anti-lacZ mRNA (Figs. 3 and 4; Table 1 ). Nevertheless, the same pattern of inhibition was seen as with j-galactosidase. The synthesis of an enzyme, alkaline phosphatase, encoded by another mRNA was not affected either by IPTG or by the anti-lacZ mRNA (Fig. 5) . Thus, in all cases, the presence of the plasmid containing lacZ in the reverse orientation was sufficient to inhibit the synthesis of 8-galactosidase, permease, and transacetylase.
When induction of E. coli 294 containing plasmid pRC23 or pBD4/lacZ'(rev) was performed with IPTG at 30°C, 13- galactosidase in both cultures increased to about the same levels (data not shown). Under these conditions, there was no inhibition of,-galactosidase synthesis in E. coli 294 containing the plasmid pBD4/lacZ'(rev), as expected, since no reverse transcript is synthesized at 30°C, where the PL promoter remains repressed. The use of anti-mnRNA that can be induced within cells provides a potent mechanism by which specific transcripts can be translationally inactivated. This procedure should provide a convenient and rapid method to determine the function of proteins or other RNAs within cells. The techniques should be applicable to eukaryotic cells with appropriate vectors and regulatory elements. During the completion of these initial experiments, Izant and Weintraub (19) reported the use of anti-mRNA in mammalian cells. Indeed, it is possible that anti-mRNA transcripts have physiological roles in cells, as suggested by Simons and Kleckner (20) and by Mizuno et al. (21) . We hope to be able to determine the optimal size and region for targeting by anti-mRNA segments in the near future. As hybrid-arrested translation has been used in vitro to screen recombinant DNA clones, antimRNA recombinants may be employed in vivo to screen and select for phenotypically altered cells lacking single functions. The method may be applicable to screen for recombinants that inhibit gene products in diploid cells where simultaneous insertional inactivation of genes is not feasible.
